0 items USD 0.00Search
Your search for "chronic hepatitis C" gave back 8736 results.
The diammonium glycyrrhizinate for injection is suitable for the treatment of chronic persistent hepatitis and chronic active hepatitis accompanied...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
According to our (Global Info Research) latest study, the global Diammonium Glycyrrhizinate for Injection market size was valued at USD million in...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Hepatitis C drugs are medications used to treat hepatitis C virus (HCV) infection. Over the years, significant advancements have been made in HCV...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria. The global Acute Hepatic Porphyria Drug...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Diammonium Glycyrrhizinate is used in the treatment of acute and chronic viral hepatitis with elevated glutamylaminotransferase. It can improve the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Recombinant human interferon α2b is a type of protein-based therapeutic product that belongs to the interferon family. It is produced using...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Hepatic Encephalopathy Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Hepatitis C drugs are medications used to treat hepatitis C virus (HCV) infection. Over the years, significant advancements have been made in HCV...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Hepatitis C Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Hepatitis C Drugs is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
